|
| Friday, 13 March 2015, 10:58 HKT/SGT | |
| |
|
|
|
|
| Debuted with more than $237 million in assets as the largest initial launch among all US listed equity ETFs since 2007 |
NEW YORK, Mar 13, 2015 - (ACN Newswire) - CSOP Asset Management Limited ("CSOP" or the "Company"), a leading offshore Chinese asset manager with the largest Renminbi Qualified Foreign Institutional Investor ("RQFII") quota, announced that its CSOP FTSE China A50 ETF (the "Fund") will begin trading today on the NYSE Arca under the ticker "AFTY". The Fund tracks the performance of the FTSE China A50 (CNHUSD) Net Total Return Index (the "Index") which provides exposure to 50 largest stocks on the Shanghai and Shenzhen Exchanges. The Fund is the first Exchange Traded Fund ("ETF") listed independently in the United States by a Chinese asset management company. The Fund has debuted with more than $237 million in assets and 13.96 million shares as the largest initial capital investment among all US listed equity ETFs since 2007.
Chinese equity market was among the world's best performing markets in 2014; the Shanghai Composite Index recorded more than 60% Year-to-Date return . The turnover of A-Share market reached a historical high and China's equity market made it as the world's second largest equity market . The ongoing Renminbi (RMB) internationalization, together with the recent liquidity injection and interest rate cut by the People's Bank of China (PBoC), will allow China's capital market to further open up and grow by attracting foreign investors. In addition, A-Share market offers diversification opportunities* to global investors due to its low correlation with regional and world portfolios.
By tracking the FTSE China A50 (CNHUSD) Total Net Return Index, the Fund offers investors exposure to the 50 largest A-Share companies by full market capitalization on the Shanghai and Shenzhen Exchanges. The Fund tracks the performance of China's onshore market while allowing investors to trade in US dollar during US trading hours, granting investors efficient trading and liquidity. With this listing, CSOP's FTSE China A50 ETF series now trades on exchanges in Asia, Europe, and North America, providing investors with round-the-clock trading platforms for Chinese equity market.
"The listing of the CSOP FTSE China A50 ETF on the NYSE ARCA offers US investors access to a transparent, efficient, and liquid solution through which they can participate in China's exciting success story**," commented Ms. Ding Chen, CSOP's Chief Executive Officer. "Our local market knowledge and expertise coupled with our status as the world's largest RQFII makes CSOP the partner of choice for investors around the world. The extension of our FTSE China A50 series into North America further enhances CSOP's offering and will serve as a cost effective*** and easy-to-understand product for institutional and individual investors who want to tap into China's A-Share market."
To commemorate this listing, CSOP's senior management team will ring the Opening Bell at the New York Stock Exchange on Monday, March 16, 2015.
*Diversification doesn't protect against losses.
**ETFs are transparent and liquid as they are exchange-traded and holdings are available daily on www.csopasset.us.
***Ordinary brokerage commissions apply.
Risk Disclaimer
- ETF Investing in China A-share market involves risks specific to China, including risks related to currency fluctuations, limited liquidity, less developed or less efficient trading markets, less government regulation, adverse political, economic and legal environment. Applicable Chinese tax rules to the ETF is at present uncertain. Uncertainties in the Chinese tax rules could have an adverse impact on ETF performance. In addition, the ETF may be more volatile than ETFs investing in a broadly diversified portfolio and developed markets.
- ETF shares are bought and sold at market price through exchange trading rather than NAV and are not individually redeemable. Shares may trade at a premium or discount to their NAV in the secondary market. Brokerage commissions will reduce returns. Returns for actual ETF investments may differ from what is shown on the website because of differences in timing, the amount invested, and fees and expenses.
Index returns are for reference only and do not reflect any management fees, brokerage expenses, transaction costs or expenses. Indexes are unmanaged and investors cannot invest directly in an index. Index returns assume that dividends have been reinvested.
An investor should consider the Funds investment objectives, risks, and charges and expenses carefully before investing. To obtain a prospectus containing this and other information, please call 1-844-209-2937 or download the file from www.csopasset.us. Read the prospectus carefully before investing.
CSOP FTSE China A50 ETF is managed by CSOP Asset Management Limited (the "Adviser"), and distributed by ALPS Distributors, Inc. ("ALPS").
Control Number: CSO000109, expiration date March 31, 2015.
About CSOP Asset Management Limited
CSOP Asset Management Limited ("CSOP") was founded in 2008 as the first offshore asset manager set up by a regulated asset management company in China. With a dedicated focus on China investing, CSOP manages public and private funds, as well as providing investment advisory services to Asian and global investors. It is the largest RMB Qualified Foreign Institutional Investor ("RQFII") asset manager globally. As of 31 Dec 2014, CSOP had US$ 7.08 billion in assets under management.
Topic: Press release summary
Sectors: Daily Finance, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership 
Monday, December 15, 2025 7:30:00 AM
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Friday, December 12, 2025 10:15:00 PM
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Friday, December 12, 2025 10:00:00 AM
|
|
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT/SGT
|
|
|
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing
Dec 11, 2025 18:09 HKT/SGT
|
|
|
Nasdaq Verafin Joins Global Anti-Scam Alliance
Dec 11, 2025 14:21 HKT/SGT
|
|
|
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards
Dec 11, 2025 12:54 HKT/SGT
|
|
|
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating
Dec 11, 2025 08:20 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
